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The Human Genome Project: 
A Molecular Approach to Defming Humanity 
Nouna Bakhiet, PhD 
Postdoctoral Research Associate 
Department of Microbiology and Molecular Genetics 
School of Medicine 
Loma Linda University 
As a fertilized egg begins its journey of embryonic develop-
ment it carries 46 chromosomes within its nucleus. The chromo-
somes are arranged in 23 pairs; one chromosome of every pair is 
from a parent. These chromosomes are made up of DNA 
molecules (geoxyribonucleic gcid). The chromosomal DNA 
material is a string of informational segments known as genes. 
Genes carry the instructions to make proteins. Proteins are the 
biofunctional building blocks oflife. The arrangement of genes 
along the chromosomal molecule constitutes a genetic map. 
Delving further, we can identify this genetic DNA molecule as 
a set of chemical subunits, the nucleotides. The order of 
nucleotides, in a certain gene, gives us the finest level of genetic 
resolution, known as the DNA sequence. 
The Human Genome Project will endeavor to map all 
known genes to their respective chromosomes and identify the 
human genome at the most refined level, the DNA sequence. 
The pursuit of this genetic knowledge and the resulting revela-
tions will expand the parameters of the scientific understanding 
of life far beyond the scope known today. When the DNA 
sequence of the entire human genome is deciphered, the 
nucleotide makeup of all now -known genes as well as unknown 
genes will be identified. This refined basis of identification 
allows us to explore life and self at a heightened new level. 
Perceived objectively, DNA sequencing of the human genome 
provides us with an improved "fingerprint" of each human. As 
the now-common fingerprint aids in uniquely identifying dif-
ferent humans, so will the genetic fingerprint identify them at a. 
molecular level. 
This form of exploration is not entirely new to science, as the 
entire genomic sequences of many viruses are known today. In 
addition, many other subhuman life forms (such as bacteria, 
fungi and protozoa) are being similarly studied. Knowing the 
genomic DNA seq uence of many viruses has helped define their 
modes of action and thus aided in the development of defense 
mechanisms against infection. Such discoveries bred the realiza-
tion of the potential preventive treatment of genetically based 
maladies. 
Gene therapy is a fast-developing technological approach 
with major medical implications. The maturation of the field of 
human gene therapy relies heavily on genetic knowledge of the 
factors involved in the practice. Hence, the Human Genome 
Project and the advancement of human gene therapy are closely 
linked, each helping to advance the other. 
In most cases, genes convey information for making proteins, 
which in turn undertake different functions in each cell. When 
a protein is absent or malfunctions in a cell, it triggers a detectable 
biological change that is generally interpreted as an aberrancy. If 
the absent or abnormal behavior of the protein is backtracked to 
a change at a single gene, it would be possible to correct the 
detectable aberrancy by simply replacing or complementing the 
defective gene's DNA sequence with a "healthy" version. This 
possibility has now become reality through the work of pioneers 
such as Dr. French Anderson. Dr. Anderson and colleagues have 
successfully complemented the biofunctional deficiency of the 
enzyme adenosine deaminase (ADA) [which leads to a form of 
severe combined immunodeficiency (SCI D) and is a product of 
a single gene]. They used a retroviral delivery system to 
introduce a correct copy of the ADA gene into deficient patients. 
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This mode of treatment is transient and has not thus far shown 
any adverse side effects in any treated patients. However, 
treatment has to be administered periodically to maintain the 
level of the cure. 
Thus, although gene therapy has become a reality, it is still 
limited in application to single gene mutations. Greater knowl-
edge of the genome may allow gene therapy to expand to include 
treatment of diseases resulting from multiple genetic mutations. 
Knowledge about genetic predisposition to certain diseases also 
is useful as a means of preventive medicine. A person who is 
aware of a possible fate would likely take action to avoid it. Such 
an example is seen in the hazards of breast cancer, where 
predisposed persons may choose to remove potentially cancer-
ous tissue, thus vastly improving their chances and quality oflife. 
Additionally, knowing oneself at the molecular genetic level. 
may increase one's life-style options. 
From a different standpoint, because results from the Hu-
man Genome Project will strengthen the field of gene therapy, 
in the future those considered the "surviving fittest" may 
include many more who otherwise would have had to accept at 
least a compromised quality of life. It must be realized that the 
Human Genome Project and the development of gene therapy 
are directed toward divulging basic knowledge and correcting or 
preventing what is defined as compromising diseases. The 
Human Genome Project may be viewed as discoveries in human 
molecular anatomy. Gene therapy may be considered as correc-
tive molecular surgery. 
Because there is no existing equivalent to the knowledge 
generated by the Human Genome Project, we can only imagine 
the potential explosion of scientific possibilities. As the changes 
come we need to be prepared to grow and modify with them. 
One of the ways to avoid panic and disharmony due to scientific 
knowledge is education. It is up to the pioneering scientists to 
extend their teachings so that others from different walks oflife 
are included in the development of a better biological under-
standing of humans-and consequently humanity .• 
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SOIne Legal Ramifications 
for Newborns 
Andrea K. Scott, JD, iliA 
Cooper, Brown, Kardaras & Schatf 
Pasadena, California 
As public debate intensifies over the merits and perils posed 
by the Human Genome Project ("the Project"),thesoleconsensus 
to emerge is that the Project wields power sufficient to alter the 
lives of each of us and our progeny. Arising out of the Project and 
resultant biotechnologies are two discrete legal causes of action 
affecting the unborn and newborn infants: "wrongful birth" and 
"wrongful life. " Al though q uite new, these causes of action have 
interesting common law antecedents. 
The first reported case in American jurisprudence to deal 
with the issue of whether or not a cause of action for damages 
could accrue to the unborn took place more than a century ago. 
In Dietrich v. Inhabitants of Northampton, 1 Justice Oliver Wendell 
Holmes rejected the proposition that an infant injured before it 
was "born alive" could be viewed as a "person" recognized by 
the law as capable of having standing or the right to present such 
a claim. Holmes' difficulty in according a fetus the right to be 
free from injury by a third person was based first on a lack oflegal 
precedent and second on the concept that an unborn infant was 
part of the mother at the time the injury occurred such that any 
recoverable damages should inure to her rather than the fetus. 2 
For many years thereafter, the judiciary followed Justice 
Holmes' ruling for four reasons. First, no duty could be estab-
lished to an unborn child who lived only as a part of the mother. 
Second, it was considered too difficul.t ~or ~cience to establis? the ( 
required causal nexus between a phYSICIan s wrongful orneghgent ~ 
act and the injury to an unborn child. Third, the courts feared an 
onslaught of spurious and extravagant claims. Fourth, the 
judiciary believed that to allow such an action was tantamount to 
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inviting similar claims by children against their mothers for 
negligent behavior during pregnancy.3 
The last half century, however, has witnessed a reversal 
unprecedented in the history of American tort law as the judi-
ciary in every state unanimously has upheld the existence of a 
cause of action on behalf of infants born with permanent dis-
abilities resulting from prenatal injuries. Even so, many ques-
tions remain unanswered. For example, courts remain divided 
on whether or not a fetus must be viable at the time an injury is 
sustained, although a majority of jurisdictions presently allow 
recovery of specific damages such as medical bills when the 
injury occurs prior to viability. A minority of jurisdictions limits 
recovery of damages for prenatal injury to cases in which the 
fetus is born alive. A few courts even allow a cause of action for 
injury which occurs prior to conception.4 
In short, a firmly entrenched notion of American tort law is 
that a physician may be held liable for negligence resulting in an 
otherwise normal child being born in a damaged condition. In 
contrast, "wrongful birth" refers to cases in which the parents 
allege a physician's negligence deprived them of the opportu-
nity to prevent the birth of a defective child. The physician's 
liability in such cases invariably stems from negligence in ge-
netic testing or genetic counseling.s 
The doctrine of informed consent and the landmark case of 
Roev. Wade,6 together provide underpinnings for wrongful birth 
actions. This is because such lawsuits are based on a negligent 
deprivation of the parents' constitutionally protected right to 
choose if they wish to have the defective offspring. In other 
words, the parents do not allege that a physician caused their 
child's abnormality, but rather that the health-care provider's 
negligence denied them the information necessary to make an 
informed decision about whether or not to conceive or continue 
the pregnancy. 
In negligent genetic testing cases, the parents generally are 
aware they may be carriers of a genetic disorder or that other 
circumstances such as the advancing age of the mother increase 
the probability of having a defective child. Consequently, the 
parents seek a health-care professional to perform genetic tests 
on themselves and the fetus. It is a provider's failure to use the 
applicable standard of care in performing and interpreting the 
results of such tests which deprives parents of an opportunity to 
avoid the birth of a defective infant. In short, the parents argue 
that had they been properly advised by the provider about the 
risk of the fetus' abnormality, their infant never would have been 
born.7 
Many other wrongful birth actions are based on allegations of 
negligent genetic counseling in which parents allege the coun-
selor failed to inform them of an increased probability of having 
a deformed child or failed to inform them about reasonably 
inexpensive tests which could determine if such deformities 
were present in the fetus. 8 Alternative grounds for a wrongful 
birth action arise from a physician's failure to diagnose a genetic 
disease in the parents' first child in time to give the parents 
,)pportunity to avoid producing a second child with the same 
defect.9 
Much more innovative than the notion of wrongful birth is 
the cause of action known as "wrongful life," which recognizes 
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the claim of an impaired child rather than that of the parents. 
The gravamen of a claim for wrongful life is that but for a 
physician's negligence, the child would not have been born to 
experience the pain, suffering and indignities he or she must 
now endure. This cause of action is based on the notion that a 
physician breached a duty owed directly or inuring derivatively 
to a child by not informing his or her parents of the risk of 
predictable abnormalities. Because the parents were thereby 
deprived of information which would have convinced them to 
decide against having the child, this breach of duty caused the 
child's birth and resultant injury of "life in an impaired state." tO 
Beginning in the late 1970s, a minority of courts allowed 
claims for wrongful life, including the Supreme Courts of Cali-
fornia, New Jersey, New York, and Washington. A majority of 
jurisdictions, however, have since rejected wrongful life claims 
for ethical, religious and policy reasons. Some courts, for example, 
have held that allowing a wrongful life claim implies that non-life 
is preferable to life in an impaired state and consequently, 
constitutes an unacceptable denial of the sanctity and worth of 
all human life. Similarly, some courts have ruled this tort is not 
justiciable or feasibly administrable because it would require 
judges to compare the harm of an impaired life with that of non-
existence when measuring damages. These courts assert such 
claims should not be allowed absent legislative enactment. 
Finally, a number of conservative courts have rejected wrongful 
life claims because the plaintiffs were unable to establish the 
fundamental elements of a standard tort claim, including a duty, 
a breach of that duty and injury} 1 
In California, the basis for liability in a wrongful life action is 
not the severity of a birth defect but rather, its predictability and 
the failure of a health-care provider to give parents the informa-
tion required by them to decide if they wish to conceive or bear 
a child which likely will be genetically defective. Additionally, 
a number of cases reveal the judiciary's view that a wrongful life 
claim should be allowed to go forward when a plaintiff child faces 
costly physical problems, even though he or she conceivably 
may lead a full and productive life. 12 
For physicians, one of the most pressing questions is what 
duty the health-care provider owes parents-who affirmatively 
seek specific medical advice regarding a genetic disorder. The 
general answer to this question is that a majority of courts impose 
on the health-care provider a duty of reasonable care, including 
an affirmative duty to disclose facts relevant to the parents' 
decision to avoid (or not) the birth of a genetically defective 
child. Some courts base this duty to disclose on a theory that 
because of the physician/patient relationship a doctor has a duty 
to advise the patient in accordance with correct medical prac-
tice.13 Other courts base this affirmative duty to disclose on a 
theory that parents have a right not to have a defective child and 
consequently, physicians have a duty to assist parents in exercis-
ing that right. 14 
Finally, we come full circle in returning to a fear enunciated 
by Justice Holmes that to grant a plaintiff's claim in tort for 
prenatal injuries might pave the way for a cause of action by a 
child against the mother for negligent behavior during preg-
nancy. In point of fact, no court in the United States has allowed 
a child to assert a wrongful life claim against his or her parents. 
3 
The California legislature recently enacted a statute l :; expressly 
prohibiting this type of suit. 
In attempting to work within the shifting parameters of this 
nascent field oflaw, one must keep in mind the fact that like the 
practice of medicine, the law evolves. Inherent in the growth 
process is initiative, reaction and reformulation. While societal 
forces tend to encourage broad acceptance of advancements in 
biotechnology, the law-by definition a conservative animal-
moves forward in modest increments. In order to serve the 
interests of all people in negotiating the marvels, blessings and 
dangers presented by the Human Genome Project, the law 
needs well-reasoned and vocal assistance from the medical, 
bioethics and religious communities as well as the public at large. 
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Ethical and Legal 
Ramifications of 
Predictive Genetic 
Information 
Manuel Aranda, Jr., JD, MA 
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In 1989, Congress ushered in a new era in genetics by 
initiating a study called "The Human Genome Project" (HGP). 
Funded by the Department of Energy and the National Insti-
tutes of Health, it is the largest biological research effort ever 
undertaken. l The HGP is not, however, solely the work of the 
United States. It is an international endeavor. The United 
Kingdom, France, Germany, Denmark and other European 
countries have already entered the race to unravel the mysteries 
of the human genome.2 
In the United States, the $3 billion Genome Project (approxi-
mately $200 million per year for 15 years) rivals the Manhattan 
Project and the Apollo moon landing program in scope.3 
The HGP will not only give biologists and physicians direct 
computer access to the secrets of our chromosomes, but will also 
provide ethicists and lawyers enough material to ponder the 
ethical and legal ramifications of humanity's tinkering with the 
human genome.4 
Perhaps the most important area of the H GP research will be 
the identification of genes that predispose individuals to disease. 
Already, genetic researchers have taken the first step of many 
steps necessary for the elimination of nearly 4,000 diseases that 
have plagued the human race for centuries.s As of 1991, the 
chromosomal location of 500 genetic disorders had been deter-
mined.6 The genes responsible for Cystic Fibrosis, Duchenne 
Muscular Dystrophy, Marfan Syndrome, Fragile X-Syndrome, 
and certain cancers have already been identified'? 
So rapid are the discoveries taking place that in the past year 
scientists have located the genes for Huntington's disease, Lou 
Gehrig's Disease, the so-called Bubble-Boy Disease, and a 
common kind of colon cancer, among others.8 
However, in the aftermath of these momentous scientific 
discoveries lies a sobering price to be paid by all of us. Genetic 
predisposition to deadly diseases is, perhaps, the most ernotion-
laden medical information that a person can have. To learn that 
one has a predisposition to cancer, Alzheimer's Disease, Sickle-
Cell Anemia, Huntington's Disease while one is asymptomatic 
can be overwhelming. 
As the amount of detailed predictive genetic information 
grows, medical scientists, physicians, and lawyers will be required .J 
to re-examine basic ethical principles of patient autonomy, 
informed consent, right of privacy, confidentiality, and justice. 
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Putting aside provocative challenges confronted by the ma-
nipulation of human genotypes and phenotypes, research on the 
uman genome will generate ethical and legal questions per-
taining to the use and dissemination of genetic information 
affecting individuals. Consider the following: 
If genetic testing reveals that an individual is carrying a 
defective gene that can result in a drastic change of his or her life-
style and of the quality of his or her life, who, other than the 
patient, has the right to know of the genetic makeup? What use 
may be made of this knowledge? 
Genetic information is valuable not only to the patient, but 
to employers, insurers, educational institutions, law enforce-
ment agencies, and others who wish to gain access to an 
individual's personal genetic profile.9 "A drop of blood, a lock of 
hair," a scraping of skin contains all the genetic information 
needed to determine whether someone is at risk of contracting 
a crippling disease or whether the accused is the perpetrator of 
the alleged crime. 10 As genetic information accumulates, many 
people may find themselves stigmatized as bad risks for insur-
ance and for employment because they are carriers of a deadly 
disease. Can employers and insurers demand its disclosure as a 
condition of employment or of receiving insurance coverage?11 
In criminal trials, will juries be technically prepared to accept 
genetic information that can go conclusively to the guilt or 
innocence of the defendant?12 
In addition, in some quarters there is the concern that the use 
of genetic information can involve the possibility of racial, ethnic 
or gender discrimination in employment practices and in health 
and life insurance coverage. 13 
Should we add laws against discrimination on grounds of 
genetic makeup to those against discrimination on grounds of 
race, religion, and gender?14 
While ethicists and lawyers may clash over the answers to 
these questions, even to the form of the question, in a larger 
sense, society itself will have to respond to rapid accumulation of 
predictive genetic information. 
How will society respond to and control the use of specific, 
detailed genetic information when such information can directly 
affect yet unborn children, even not-yet-conceived children? 
Scientists have already developed highly reliable tests for the 
detection of the gene associated with the Fragile X-Syndrome. 
Consequently, mentally normal men and women who carry a 
"silent" version of the gene that can lead to retardation in 
children or grandchildren can be identified. Is 
How will society respond to the use of specific and detailed 
genetic information when scientists uncover the gene( s) involving 
antisocial behavior and mental distress?16 How will society 
control the dissemination of genetic information when such 
information links homosexuality and alcoholism to genetic 
makeup?17 Failure to safeguard the confidentiality of such 
information could affect a person's employment, insurability, 
and privacy. 
With these questions in mind, and with no answers in hand, 
a list of the major ethical issues that ought to govern the attitudes 
and actions of genetic researchers, physicians, genetic counsel-
ors, and lawyers is presented. 
Autonomy. Preeminent in the principle of autonomy is the 
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idea of respect. To respect a person's autonomy means to 
recognize that every person has the right of self-determination, 
the right to make his own decisions about the life he or she is to 
live and how he or she is to live it. Respect means not to interfere, 
usurp or limit the individual's choices or beliefs, even if we may 
believe his or her choice or belief is wrong or foolish. 
In the arena of genetic information, respect for the individual's 
autonomy means that the patient ought to have the final word as 
to the use and dissemination of genetic information that affects 
his or her life or death. 
Securely grounded to the principle of autonomy is the 
principle of confidentiality. New genetic discoveries pertaining 
to gene-caused diseases will result in genetic screening and 
testing that will uncover a great deal of predictive genetic 
information. A patient may want such information to be kept 
confidential. I8 
Should we add laws against 
discrimination on grounds of 
genetic makeup to those against 
discrimination on grounds of 
race, religion, and gender.~ 
Ought the physician breach the confidentiality relationship in 
order to pass on "genetic news" to the immediate family? Or, 
should he maintain that relationship even though harm to third 
parties may be certain, but in the distant future? Is harm to third 
parties the ethical justification for the breach of a confidential 
relationship? 
Non-maleficence is the duty to minimize or prevent the inflic-
tion of harm on an individual or on families. Since Hippocrates 
wrote the words, "I will abstain from all wrong-doing and harm," 
the medical profession has taken these words and fashioned 
them into a practical medical ethic, Primum non tlOCere, "Above 
all, do no harm." Revelation of genetic information to the patient 
when it is not wanted or dissemination of "genetic news" to third 
parties can cause serious psychological and emotional harm. 
"Experience has shown that the process of explaining genetic 
risks is complex; understanding comes slowly and painfully. 
The psychological burdens of genetic disease can be massive 
and not everyone wants to know his or her own risk." 19 Can harm 
to the patient be avoided? 
Beneficence, in the context of dissemination of genetic infor-
mation, requires the physician or genetic counselor to abstain 
from harming others and to take positive steps to assist others to 
further their interests largely by removing or preventing possi ble 
harm.20 How is beneficence manifested when one is dealing 
with rare diseases that in an earlier time might have been 
explained as a manifestation of fate or of God's judgment, and 
now must be explained in terms of genetic makeup? How can 
present harm be avoided and the future interest of a family 
5 
protected by informing a person that his or her presently 
asymptomatic children may develop a deadly disease? 
Informed Consent. If a person is to make decisions about his or 
her life and family, those decisions ought to be informed. A 
person's autonomy is respected when enough information is 
given as to what genetic testing will reveal and how that infor-
mation may affect family, employment, insurance coverage and 
future health. With such information the patient will be able to 
make an informed decision to accept or reject genetic testing. 
Justice. The concept of justice informs us that similar people 
in similar circumstances ought to be treated similarly. But, 
therein is the rub. If an individual has been tested and found to 
be a carrier of a defective gene that will later result in a crippling 
disease, and, commensurate therewith, enormous medical costs, 
will that information consign him or her to a "biological 
underclass?"21 In matters of employment, education and in-
surance will he or she be treated the same as the person who 
refuses genetic testing? 
The discoveries of medical scientists will increase our under-
standing of the relationshi p between a person's genetic traits and 
his or her future health risks and, hopefully, increase our aware-
ness of the ethical ramifications of predictive information. 
In the end, the success of scientific discoveries by HGP 
researchers will be measured not only by their alleviations of 
human suffering but by their uncompromising willingness to 
maintain moral imperatives. There must be ethical limits to the 
search for knowledge. 
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MA Program (continued from page 8) 
Students are required to complete 48 quarter units 
including the required courses listed below. 
RELE 504 Research Methods (4) 
Presuppositions and procedures for research in the 
humanities and sciences pertinent to specialists in ethics; 
the use of libraries as research centers; advanced methods 
of expository and persuasive writing; ways and means of 
preparing and presenting term papers, theses, and scholarly 
articles. 
RELE 524 Christian Bioethics (4) 
A discussion of current bioethical controversies such as 
abortion, euthanasia, allocating scarce medical resources, 
mind and behavior control, and artificial methods of human 
procreation. Analysis of a variety of Christian and non-
Christian interpretations of these and related issues. Alter-
native understandings of Christianity's distinctive contri-
butions to bioethical inquiry. 
RELE 548 Christian Social Ethics (4) 
An in-depth opportunity for the graduate students to 
discover the implications of Christian belief for selected 
'problems in social ethical theory and practice. 
RELE 554 Clinical Intensive in Biomedical Ethics (4) 
An intensive study of the theories and applications of 
clinical biomedical ethics. Discussion of classic and current 
case studies in the field. Supervised participation in ethics 
consultation in acute care medical centers. 
RELE 555 Clinical Intensive in Biomedical Ethics (4) 
Continuation of RELE 554 
RELE 577 Theological Ethics (4) 
Ethical dimensions of theological positions advocated 
in the twentieth century. 
RELE 588 Types of Ethical Theory (4) 
A critical analysis of basic theories propounded in philo-
sophical ethics and their relevance to bioethical decision-
making. A study of the writings of major ethical theorists, 
including Plato, Aristotle, Immanuel Kant, and}. S. Mill. A 
consideration of philosophical ethics as compared with the 
Christian faith. 
,ELE 697 Independent Research (8) plus 
RELE 698 Thesis (4) or Approved electives (12) 
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FACULTY 
LEIGH BISHOP, MD, MA 
University of Texas, Galveston, 1980 
University of California, Riverside, 1992 
Associate Professor of Psychiatry and Medical Philosophy 
DAVID R. LARSON, OM in, PhD 
School of Theology at Claremont, 1973 
Claremont Graduate School, 1982 
Program Coordinator 
Professor of Christian Ethics 
Co-Director, Center for Christian Bioethics 
ROBERT D. ORR, MD 
McGill University, 1966 
Associate Professor of Family Medicine 
Director of Clinical Ethics, LLUMC 
Co-Director, Center for Christian Bioethics 
JACK W. PROVONSHA, MD, PhD 
Lorna Linda University, 1953 
Claremont Graduate School, 1967 
Emeritus Professor of Philosophy of Religion and Christian Ethics 
JAMES W. WALTERS, PhD 
Claremont Graduate School, 1979 
Professor of Christian Ethics 
GERALD R. WINSLOW, PhD 
Graduate Theological Union, 1979 
Dean, Faculty of Religion 
Professor of Christian Ethics 
ASSOCIATE FACULTY 
ROY BRANSON, PhD 
Harvard University, 1968 
Adjunct Professor of Christian Ethics 
CHARLES W. TEEL, Jr., PhD 
Boston University, 1972 
Adjunct Professor of Christian Ethics 
LOIS VAN CLEVE, PhD 
Claremont Graduate School, 1985 
Professor of Nursing 
CLINICAL FACULTY 
DENNIS DeLEON, MD 
University of Tennessee, Memphis, 1989 
Assistant Professor of Family Medicine 
Clinical Ethics, LLUMC 
STEVEN B. HARDIN, MD 
Lorna Linda University, 1985 
Assistant Professor of Medicine 
Clinical Ethics 
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GRADUATE PROGRAM COMBINES 
BIOMEDICAL AND CLINICAL ETHICS 
The Graduate School at Lorna Linda University offers 
an interdisciplinary program leading to a Master of Arts 
degree in Biomedical and Clinical Ethics. This program 
allows students to explore historic traditions of ethical 
thought, gain clinical experience in the medical setting, 
and develop critical skills for applying theory and values to 
contemporary moral and social issues. 
The program in Biomedical and Clinical Ethics is es-
pecially valuable for those preparing for careers as hospital 
chaplains, clinical ethicists, nurses, physicians, and other 
health-care professions. It is specifically designed for two 
types of students: (1) those who are pursuing this degree in 
order to enhance their existing careers in related fields, and 
(2) those who are pursuing this degree as a stepping stone 
to a doctorate in philosophy, theology, ethics, medicine, 
nursing, law, or other related fields. The MA in Biomedical 
and Clinical Ethics is an excellent opportunity to balance a 
To request further information and applications for the 
MA program in Clinical and Biomedical Ethics, write: 
Office of the Dean 
Graduate School 
Lorna Linda University 
Lorna Linda, California 92350-0001 
Phone (909) 824-4529 FAX (909) 824-4859 
CENTER FOR CHRISTIAN BIOETHICS 
Lorna Linda University 
Lorna Linda, CA 92350 
theoretical understanding of ethics with practical applica-
tion in the clinical setting. 
The faculty for this program is committed to exploring 
ethical issues in medicine and related fields from Christian 
perspectives. Students come from a variety of religious and 
cultural backgrounds. A mutual and shared respect for 
various cultures and beliefs is emphasized on the campus 
and in the classroom. 
The faculty offering courses in biomedical and clinical 
ethics is composed of scholars in Biblical and religious 
studies, bioethics, sociology of religion and ethical theory. 
F our members of the faculty are physicians with training 
and professional experience in clinical ethics. This con-
centration of diverse specialists provides the MA student 
with a rich opportunity to benefit from a variety of ap-
proaches to the fields of biomedical and clinical ethics 
resulting in a balanced program of study. 
The Center for Christian Bioethics at Lorna Linda 
University provides opportunities for students to partici-
pate in the workings of an active ethics institute. The 
Center for Christian Bioethics also possesses an extensive 
bioethics library. The Center sponsors monthly Ethics 
Grand Rounds featuring guest speakers and current issues 
in medicine and ethics. As a premier teaching and research 
hospital, Lorna Linda University lV1edicai Center is an 
excellent setting for the clinical aspects of this program. 
(Continued on page 7) 
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